Market Capitalization (Millions $) |
624 |
Shares
Outstanding (Millions) |
27 |
Employees |
- |
Revenues (TTM) (Millions $) |
17 |
Net Income (TTM) (Millions $) |
-164 |
Cash Flow (TTM) (Millions $) |
-35 |
Capital Exp. (TTM) (Millions $) |
1 |
Anaptysbio Inc
AnaptysBio Inc. is a biotechnology company that focuses on the discovery and development of antibody therapeutics. The company harnesses the power of its proprietary somatic hypermutation (SHM) platform to generate novel antibodies for various diseases across different therapeutic areas. Through its platform, AnaptysBio can create fully human antibodies with improved binding affinity, specificity, and potency, thereby potentially providing more effective treatments for patients. The company collaborates with pharmaceutical partners to advance its pipeline of antibody candidates, aiming to address unmet medical needs and make a positive impact in the field of biopharmaceuticals.
Company Address: 10770 Wateridge Circle San Diego 92121 CA
Company Phone Number: 362-6295 Stock Exchange / Ticker: NASDAQ ANAB
|